Myxoid Liposarcoma — Trials

Myxoid Liposarcoma — Trials · CancerIndex

Clinical trials

Registered studies

31 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 12
Recruiting: 6
Ph III recruiting: 0
Growth YoY: —
Industry share: 42%
Top sponsor: USWM CT, LLC
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (6)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07686367	Testing the Anti-Cancer Drug, Brenetafusp (IMCF106C), in Rare Cancers	not yet recruiting	Phase 2	42	National Cancer Institute (NCI)NIH	0	Sep 25, 2026	clinicaltrials
NCT06843967	A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma	recruiting	Phase 1 / Phase 2	54	Memorial Sloan Kettering Cancer CenterOTHER	1	Sep 16, 2026	clinicaltrials